VitalSigns, a spin-off from Aalto University in Finland, is at the forefront of healthcare innovation. We are developing a next-generation smart and connected multimodal diagnostic device that leverages cutting-edge artificial intelligence and machine learning to analyze biosignals with precision and efficiency. Our solution aims to revolutionize diagnostic processes for medical professionals and, in the future, for consumers at home. Backed by secured funding, we are on track to finalize development by 2025, with medical device certification and a product launch planned for late 2025 or early 2026.